Skip to main content

Stamos Capital Partners, L.P.

Position in GILD — Gilead Sciences, Inc.

CIK 1705399 Menlo Park, CA

Position in GILD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$854,437
+$47,764 QoQ
Shares Held
6,763
+16.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,145
of 2,266 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Stamos Capital Partners, L.P. holds $64,248,987 across 8 Drug Manufacturers - General names. GILD ranks #7 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 GILD
Gilead Sciences, Inc.
This page
6,763 $854,437

All Filings in GILD

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $854,437 6,763
2026-03-31 $806,673 5,788
2025-12-31 $894,283 7,286
2025-09-30 $523,920 4,720
2025-06-30 $851,814 7,683
2025-03-31 $854,269 7,624
2024-12-31 $1,242,376 13,450
2024-09-30 $2,763,366 32,960
2024-06-30 $2,971,499 43,310
2024-03-31 $2,678,020 36,560
2023-12-31 $2,478,906 30,600
2023-09-30 $3,395,531 45,310
2023-06-30 $3,424,990 44,440
2023-03-31 $3,104,737 37,420
2022-12-31 $2,725,737 31,750
2022-09-30 $2,939,528 47,650
2022-06-30 $1,310,372 21,200
2022-03-31 $1,260,340 21,200
2020-12-31 $2,953,782 50,700
2020-03-31 $1,005,821 13,454